Chemotherapy-Induced Endothelial Dysfunction: a Bibliometric Analysis of Research Trends from 1994 to 2024
Open Access
- 16 September 2025
- journal article
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 22 (5) , 24-33
Abstract
Chemotherapy-induced endothelial damage is a complex issue characterized by cardiovascular toxicity and cellular injury. This study aims to analyze primary research areas related to chemotherapy-induced endothelial dysfunction, focusing on countries, institutions, journals, authors, and keywords. Methods. The research employs a descriptive bibliometric design to collect and analyze data from 3,430 publications indexed in the Web of Science and Scopus databases, spanning the years 1994-2024. The bibliometric analysis includes English-language research articles and review papers examining endothelial dysfunction in chemotherapy patients. Data analysis was conducted using RStudio and the Bibliometrix R package, with VOSviewer utilized for visualization. Results. The annual publication trend reveals fluctuations, peaking in 2005 while showing sustained interest in recent years. The United States leads in publication volume with 1,328 articles, closely followed by China and Japan. High levels of international collaboration were noted, particularly between the United States and European countries. Key contributing institutions include Harvard Medical School in the USA and the National Cancer Institute, while prominent authors such as Wang and Kim make significant contributions to the field. "Cancer Research" is recognized as one of the most influential journals, highlighting the interdisciplinary relevance of this field. Conclusions. This bibliometric analysis highlights the evolving key research trends related to angiogenesis, VEGF inhibitors, and the need to increase international cooperation. Given the recent introduction of new classes and groups of chemotherapeutic drugs into practice and the growing body of knowledge in this area, a renewed surge of interest in this topic can be anticipated.Keywords
This publication has 25 references indexed in Scilit:
- Cardiovascular Considerations After Cancer TherapyJACC: Cardiooncology, 2025
- Global trends in research on endothelial cells and sepsis between 2002 and 2022: A systematic bibliometric analysisHeliyon, 2023
- Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort studyESMO Open, 2022
- Nitric oxide bioavailability dysfunction involves in atherosclerosisBiomedicine & Pharmacotherapy, 2018
- Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target siteLeukemia, 2017
- Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implicationsCancer Treatment Reviews, 2012
- Mechanisms of adverse effects of anti-VEGF therapy for cancerBritish Journal of Cancer, 2007
- Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular riskCanadian Journal of Cardiology, 2006
- Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)International Journal of Cancer, 2003
- Long-term chemotherapy-related cardiovascular morbidityCancer Treatment Reviews, 2000